For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the emergence of this treatment and Tafamidis meglumine represents a true change. These groundbreaking therapies preserve the transthyretin protein, halting its damaging build-up and lessening the severity of the condition . People are now experienc… Read More